We analyzed trends in patients’ characteristics, outcomes, and waiting times over the last 25?years at our epilepsy surgery center situated in Central Europe to highlight possible areas of improvement in our care for patients with drug-resistant epilepsy.
Diacomit (stiripentol) was safe and clinically effective at reducing seizures when given to infants with Dravet syndrome, ages 2 or younger.
We reviewed the clinical and genetic characteristics of children with epilepsy related to GATOR1 variants
Several new antiseizure medications have recently been introduced to the market, making it possible to better tailor the treatment of epilepsy, as well as other indications (psychiatry and pain disorders).
Northwestern Medicine investigators have shown that inhibiting a mutated gene can reduce seizure activity in adult-type diffuse gliomas
we were looking for a less invasive way to try to help all the children with drug resistant epilepsy.
“We need to come together as a community and begin to discuss what's out there, set standards, and lay down some guidelines,”
New research has shown for the first time how the commonly prescribed seizure and pain medication, gabapentin, acts inside of cells, opening the door to new, more effective treatments for diseases like epilepsy and Lupus.
The Medtronic Registry for Epilepsy (MORE) aims to assess ANT DBS therapy’s safety and longer-term effectiveness in routine clinical practice.
